The energy-dependenttransport of D-glucose via SGLT2 may exacerbate the energy deficit observedduring cerebral ischemia, suggesting that SGLT2 inhibition could providetherapeutic benefits in this context [53]. Here, SLC5A2 is linked to brain ischemia.